To further validate that TGF-β signaling is responsible for the c-kit-induced EMT and the enhanced cell motility, we used a specific TGF-β receptor kinase inhibitor SB431542 to block the TGF-β signaling in c-kit-expressing ACC-M cells. The gene discussed is TGFB1; the disease is adrenal cortex carcinoma.